Pathophysiology, Diagnosis and Treatment of Immune Thrombocytopenia

Pathophysiology, Diagnosis and Treatment of Immune Thrombocytopenia

Immune thrombocytopenia (ITP) is an acquired disorder characterized by isolated thrombocytopenia with a peripheral blood count < 100.000/ mm3 in the absence of any obvious initiating or underlying causes, by antibody mediated destruction of platelets and suppression of megakaryocyte and platelet...

Full description

Bibliographic Details
Main Authors:	Mihnea-Alexandru Găman, Amelia Maria Găman
Format:	Article
Language:	English
Published:	University Library System, University of Pittsburgh 2017-03-01
Series:	International Journal of Medical Students
Subjects:	primary immune thrombocytopenia, itp guidelines thrombopoietin receptor agonists splenectomy immune thrombocytopenic purpura
Online Access:	http://ijms.info/IJMS/article/view/171

Similar Items

Older Adults and Immune Thrombocytopenia: Considerations for the Clinician
by: Crickx E, et al.
Published: (2023-01-01)

Clinical Presentation and Therapy of Primary Immune Thrombocytopenia Resistant to Splenectomy
by: Aleksandar Kara-Jovanović, et al.
Published: (2020-04-01)

Re-Visiting Immune Thrombocytopenia with Covid-19 Vaccination: A Case Report
by: Abhishek Samprathi, et al.
Published: (2022-03-01)

Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical Practice
by: Song F, et al.
Published: (2021-07-01)

Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine
by: Helms JM, et al.
Published: (2021-04-01)

Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenic purpura: meta-analysis
by: Joyce Tumaini Massaro, et al.
Published: (2019-10-01)

Advances in management of pediatric chronic immune thrombocytopenia: a narrative review
by: Jae Min Lee
Published: (2023-07-01)

Protocolo de estudio y tratamiento de la trombocitopenia inmune primaria: PTI-2018
by: Emilio Monteagudo, et al.
Published: (2019-08-01)

Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States
by: McGrath LJ, et al.
Published: (2020-05-01)

Late but effective and durable response to splenectomy in a patient with very 20 years-lasting immune thrombocytopenia and thrombophilic diathesis.
by: Pasquale Niscola
Published: (2014-08-01)

Emerging Concepts in Immune Thrombocytopenia
by: Maurice Swinkels, et al.
Published: (2018-04-01)

Laparoscopic Splenectomy for Immune Thrombocytopenic Purpura (ITP)
by: Muhammad Arham, et al.
Published: (2018-06-01)

Second-line and beyond: treatment options for primary persistent and chronic immune thrombocytopenia
by: Samuel Deshayes, et al.
Published: (2020-04-01)

Evaluation of 143 Cases of Immune Thrombocytopenic Purpura With Regards to Clinical Course and Response to Treatment
by: Murat Albayrak, et al.
Published: (2010-12-01)

Recent advances in the mechanisms and treatment of immune thrombocytopenia
by: Drew Provan, et al.
Published: (2022-02-01)

Comparison of dexamethasone and Anti-D Immune globulin for immune thrombocytopenia purpura in children
by: Abdollah Banihashem, et al.
Published: (2014-04-01)

Use of thrombopoietin receptor agonists in childhood immune thrombocytopenia
by: Angelica Maria Garzon, et al.
Published: (2015-08-01)

Thrombopoietin Receptor Agonists in the Treatment of Chronic Resistant Primary Immune Thrombocytopenia: Efficacy and Safety Data in Real Clinical Practice
by: V V PTUSHKIN, et al.
Published: (2018-07-01)

Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives
by: Tsykunova G, et al.
Published: (2022-03-01)

Treatment of patients with refractory immune thrombocytopenia: literature review and case report
by: V. V. Ptushkin, et al.
Published: (2014-07-01)

Treatment of patients with refractory immune thrombocytopenia: literature review and case report
by: V. V. Ptushkin, et al.
Published: (2014-07-01)

Immune Thrombocytopenic Purpura in a Patient with Atopic Dermatitis Treated with Dupilumab
by: Surina Frey, et al.
Published: (2021-03-01)

Idiopathic thrombocytopenic purpura: laboratory diagnosis and management
by: Alvina
Published: (2011-08-01)

Idiopathic thrombocytopenic purpura: laboratory diagnosis and management
by: Alvina Alvina
Published: (2016-02-01)

Eltrombopag for the Treatment of Immune Thrombocytopenia: The Aegean Region of Turkey Experience
by: Füsun Özdemirkıran, et al.
Published: (2015-12-01)

Eltrombopag for the Treatment of Immune Thrombocytopenia: The Aegean Region of Turkey Experience
by: Füsun Özdemirkıran, et al.
Published: (2015-11-01)

Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy
by: A. G. Solodovnikov, et al.
Published: (2020-12-01)

Effect of thrombopoietin-receptor agonists on circulating cytokine and chemokine levels in patients with primary immune thrombocytopenia (ITP)
by: Sif Gudbrandsdottir, et al.
Published: (2017-07-01)

Thrombopoietin receptor agonists in pharmacotherapy of pediatric immune thrombocytopenia
by: Olga S. Levchenkova, et al.
Published: (2023-03-01)

Association between megakaryocyte abnormalities on bone marrow smear and response to thrombopoietin receptor agonists in adult patients with primary immune thrombocytopenia
by: Ondine Walter, et al.
Published: (2022-11-01)

Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP)
by: Rick Kapur, et al.
Published: (2020-04-01)

Effect of Thrombopoietin Receptor Agonist on Pregnant Mice
by: Kensaku Nakai, et al.
Published: (2022-02-01)

Clinical statistics and effectiveness of different treatments of idiopathic thrombocytopenic purpura
by: Lidiya Grigor'evna Kovaleva, et al.
Published: (2011-04-01)

Clinical Phenotype and Response to Different Lines of Therapy in Elderly with Immune Thrombocytopenia: A Retrospective Study
by: Mancuso S, et al.
Published: (2020-08-01)

Immune Thrombocytopenic Purpura
by: Teny Tjitra Sari
Published: (2018-08-01)

Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extension
by: Hanny Al‐Samkari, et al.
Published: (2022-02-01)

Eltrombopag Use in Children with Persistent and Chronic Primary Immune Thrombocytopenia in a Portuguese Pediatric Center
by: Caroline Lopes, et al.
Published: (2024-04-01)

Feasibility of romiplostim discontinuation in adult thrombopoietin-receptor agonist responsive patients with primary immune thrombocytopenia: an observational retrospective report in real life clinical practice
by: Monica Carpenedo, et al.
Published: (2015-02-01)

Dengue hemorrhagic fever as a rare cause of chronic immune thrombocytopenic purpura—a pediatric case report
by: V. Thadchanamoorthy, et al.
Published: (2020-07-01)

The role of hydroxychloroquine as a steroid-sparing agent in the treatment of immune thrombocytopenia: A review of the literature
by: Fatemeh Mohammadpour, et al.
Published: (2018-01-01)